VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PBH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PBHPrestige Consumer Healthcare Inc.
$48.03$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPBHCash Flow

Prestige Consumer Healthcare Inc. (PBH) Cash Flow Statement

26Y historyFree accessUpdated daily

Prestige demonstrates high earnings quality with an OCF/NI ratio consistently averaging above 1.20, supported by an asset-light model where capital expenditures represent only 0.8% of revenue.

PBH Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01
Cash from Operations265.41M251.51M248.93M229.72M259.92M235.61M217.12M189.28M210.11M147.77M174.35M156.25M111.58M137.6M67.45M86.67M59.43M66.68M44.99M71.9M53.86M51.04M6.14M12.52M3.94M1.98M
Operating CF Margin %24.38%22.11%22.12%20.37%23.92%24.98%22.55%19.4%20.18%16.75%21.62%21.87%18.54%22.07%15.29%25.76%19.68%21.32%13.77%22.56%18.16%16.83%6.98%17.45%8.52%22.85%
Operating CF Growth %5.52%1.04%8.36%-11.62%10.32%8.51%14.71%-9.91%42.19%-15.24%11.58%40.04%-18.91%104%-22.17%45.84%-10.88%48.21%-37.43%33.49%5.52%731.71%-50.98%217.74%99.19%-
Net Income190.3M214.6M209.34M-82.31M205.38M164.68M142.28M-35.8M339.57M69.39M99.91M78.26M72.61M65.5M37.21M29.22M31.86M-186.78M33.92M36.08M26.28M13.46M4.18M-14.9M545K2.53M
Depreciation & Amortization31.27M30.17M30.68M32.63M32.09M30.16M29M31.78M33.43M25.79M23.68M17.74M13.49M13.23M10.73M10.11M13.38M11.22M14.02M13.64M13.43M12.74M5.43M5.27M3.99M0
Stock-Based Compensation011.16M14.01M12.4M9.04M8.54M7.64M7.44M8.91M8.15M9.95M6.92M5.15M3.77M3.08M3.58M2.08M2.44M1.14M655K383K00000
Deferred Taxes22.7M023.07M-60.77M9.98M18.63M13.85M-40.55M-269.09M-5.78M46.15M28.92M19.01M25.5M13.79M9.32M11.01M-19.95M10.1M9.66M14.98M7.2M2.41M000
Other Non-Cash Items30.98M37.52M11.66M381.61M14.38M19.19M15.55M234.74M113.05M63.55M16.44M11.09M13.27M16.98M8.07M3.09M4.92M251.82M1.14M655K9.32M26.86M514K22.14M-597K-550K
Working Capital Changes-9.84M-41.94M-39.83M-53.85M-10.95M-5.6M8.8M-8.32M-15.76M-13.34M-21.78M13.33M-11.95M12.6M-5.43M31.36M-3.83M7.93M-14.19M11.86M-10.52M-9.22M-7.81M000
Change in Receivables-3.69M-16.33M-6.32M-24.93M-24.65M36.87M-2.85M-2.98M-5.04M-18.94M1.82M1.61M9.73M-12.88M-15.85M4.92M6.4M8.19M-9.05M4.88M-1.35M-12.84M0000
Change in Inventory-1.6M-9.31M24.44M-42.23M663K2.97M2.93M-10.54M-2.48M-10.26M-3M15.36M-2.85M-9.34M3.71M12.44M-3.35M2.72M477K4.29M-7.16M5.26M-1.19M000
Change in Payables-151K-19.41M-24.97M7.26M9.15M-17.34M6.21M-3.99M-10.03M21.45M-11.35M-17.64M-4.64M24.68M5.13M1.78M-3.13M-2.27M-975K-186K-6.04M5.06M0000
Cash from Investing-136.84M-17.45M-20.11M-11.58M-256.51M-22.24M-16.57M55.43M-11.56M-694.6M-222.97M-805.26M-57.98M11.22M-662.21M-275.68M7.32M-4.67M-537K-31.05M-54.16M-425.84M-167.45M-2.17M-4.41M0
Capital Expenditures-11.18M-8.22M-9.55M-7.78M-9.64M-22.24M-14.56M-10.48M-12.53M-2.98M-3.57M-6.1M-2.76M-10.27M-606K-655K-673K-481K-521K-540K-23.17M-365K-618K-421K-95K0
CapEx % of Revenue1.03%0.72%0.85%0.69%0.89%2.36%1.51%1.07%1.2%0.34%0.44%0.85%0.46%1.65%0.14%0.19%0.22%0.15%0.16%0.17%7.81%0.12%0.7%0.59%0.21%-
Acquisitions-123.74M-9.23M-10.56M-3.8M-246.87M0-2.76M65.91M0-693.12M-226.98M-809.16M-55.22M21.47M-661.6M-275.04M7.99M-4.19M0-31.26M-30.99M-425.48M-167.53M000
Investments--------------------------
Other Investing-1.93M00000750K65.91M970K1.5M7.58M10M3K15K-662.21M12K7.99M-481K-16K750K-54.16M-425.48M700K-1.74M-4.32M0
Cash from Financing-163.84M-182.07M-241.01M-185.85M-7.57M-279.42M-131.43M-249.33M-208.96M561.86M54.04M643.26M-41.15M-152.12M600.43M161.25M-60.83M-32.9M-52.13M-35.29M3.17M376.74M163.34M-14.71M5.53M36.49M
Debt Issued (Net)-7.28M-139.54M-227.83M-137.75M-5.58M-251.44M-68.48M-200M-209M569.5M58.9M656.1M-47.97M-158.15M633.1M162.1M-60.83M-32.89M-52.13M-35.28M3.27M168.97M60.54M000
Equity Issued (Net)-152M-36.71M-25M-50M0-11.87M-56.72M-47.05M0-1.43M7.23M-2.1M-744K0000-16K0-10K-89K245.47M100.37M000
Dividends Paid00000000000000000000000000
Share Repurchases-156.28M-51.51M-25M-50M0-11.87M-56.72M-49.98M-1.07M-1.43M-2.23M-2.1M-744K0000-16K0-10K0-4K0000
Other Financing-4.57M-5.83M11.81M1.91M-1.99M-16.11M-6.23M-2.28M45K-6.21M-12.1M-10.73M7.56M6.03M-32.67M-852K00-7K0-13K-37.7M2.43M-14.71M5.53M36.49M
Net Change in Cash-34.02M51.41M-12.02M31.3M-5.12M-62.46M67.23M-5.02M-9.31M14.63M5.91M-7.01M12.66M-3.35M5.68M-27.76M5.92M29.1M-7.68M5.56M2.87M1.94M-137K-14.71M5.53M38.47M
Free Cash Flow254.23M243.29M239.38M221.93M250.28M213.36M202.56M178.8M197.58M144.79M170.78M150.15M108.82M127.34M66.85M86.02M58.75M66.2M44.47M71.36M30.69M50.68M5.52M12.1M3.85M1.98M
FCF Margin %23.35%21.38%21.27%19.68%23.03%22.62%21.03%18.32%18.98%16.42%21.18%21.01%18.08%20.42%15.15%25.56%19.45%21.17%13.62%22.4%10.34%16.71%6.28%16.87%8.31%22.85%
FCF Growth %4.5%1.64%7.86%-11.33%17.3%5.33%13.29%-9.5%36.45%-15.22%13.74%37.99%-14.54%90.49%-22.29%46.4%-11.25%48.87%-37.68%132.54%-39.45%818.23%-54.38%214.64%94.39%-
FCF per Share5.224.864.774.454.924.223.963.433.692.713.212.852.082.481.321.711.171.330.891.430.611.840.210.240.140.07
FCF Conversion (FCF/Net Income)1.39x1.17x1.19x-2.79x1.27x1.43x1.53x-5.29x0.62x2.13x1.75x2.00x1.54x2.10x1.81x2.97x1.85x-0.36x1.33x1.99x2.05x3.79x1.47x-0.84x7.23x0.78x
Interest Paid047.8M63.25M54.24M61.36M80.29M92.17M98.23M98.57M85.21M79.13M70.16M62.36M-69.64M-34.98M-17.51M-24.82M26.75M00000000
Taxes Paid052.12M59.64M40.74M46.57M34.38M30.6M32.8M24.44M48M15.35M-11.94M-11.02M-10.62M-12.87M-11.89M-15.49M9.84M00000000

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Organic revenue contraction

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Earnings Quality Remains Consistently High

According to the provided cash flow statements, PBH consistently generates operating cash flow in excess of net income, with an OCF/NI ratio averaging above 1.20 over the last ten quarters, suggesting that the company's reported earnings are supported by tangible cash generation rather than aggressive accounting accruals.

The persistent premium of operating cash flow over net income indicates that non-cash charges, primarily amortization of acquired intangibles, are significant. This suggests that the company's underlying cash-generative capacity is stronger than GAAP net income implies, providing a buffer for capital allocation.

Free Cash Flow Resilience Amid Contraction

As reported in financial statements, PBH maintained a stable free cash flow margin averaging approximately 22% over the last ten quarters, even as top-line growth turned negative, demonstrating the company's ability to preserve cash through disciplined cost management despite the ongoing challenges in organic revenue performance.

The stability of FCF margins suggests that the asset-light business model effectively insulates the bottom line from volume volatility. Investors should monitor whether this margin profile can be sustained if the company is forced to increase marketing spend to combat the current revenue decline.

Minimal Capital Intensity Supports Cash

Based on PBH's reported figures, capital expenditures remain remarkably low, averaging roughly 0.8% of revenue over the observed period, which confirms the company's asset-light strategy and minimizes the burden of maintenance capex on the firm's overall free cash flow generation and liquidity profile.

The low capital intensity is a structural advantage that allows the company to convert a high percentage of operating profit into free cash flow. This minimal requirement for reinvestment suggests that the company is well-positioned to pivot toward debt reduction or share repurchases as needed.

Aggressive Capital Return Amid M&A

Data from recent filings indicates that PBH has utilized its free cash flow to fund significant share repurchases, totaling over $150 million in the last ten quarters, while simultaneously managing acquisition activity, reflecting a balanced approach to capital deployment that prioritizes shareholder returns alongside inorganic growth strategies.

The use of cash for buybacks during a period of negative revenue growth may signal management's confidence in the long-term value of the brand portfolio. However, investors should scrutinize whether these repurchases are effectively offsetting dilution or if they are diverting capital from necessary brand revitalization efforts.

PBH — Frequently Asked Questions

Quick answers to the most common questions about buying PBH stock.

How much cash does Prestige Consumer Healthcare Inc. (PBH) generate from operations?

Prestige Consumer Healthcare Inc. (PBH) generated $265.4M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Prestige Consumer Healthcare Inc.'s free cash flow?

Prestige Consumer Healthcare Inc. (PBH) generated $254.2M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Prestige Consumer Healthcare Inc.'s capital expenditure (CapEx)?

Prestige Consumer Healthcare Inc. (PBH) spent $11.2M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Prestige Consumer Healthcare Inc. distribute cash to shareholders?

In 2026, Prestige Consumer Healthcare Inc. (PBH) spent $156.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.